Nerea Zabaleta

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Left Ventricular

Hypertrophic Cardiomyopathy

Top Venues

Nature medicine

EMBO molecular medicine

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Torella, Julia Klermund, Martin Bilbao-Arribas, Ibon Tamayo, Geoffroy Andrieux, Kay O Chmielewski, Africa Vales, Cristina Olagüe, Daniel Moreno-Luqui, Ivan Raimondi, Amaya Abad, Julen Torrens-Baile, Eduardo Salido, Maite Huarte, Mikel Hernaez, Melanie Börries, Toni Cathomen, Nerea Zabaleta, Gloria Gonzalez Aseguinolaza
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO molecular medicine 16 (1) (2024)
Urja Bhatt, Cecile Herate, Reynette Estelien, Francis Relouzat, Nathalie Bosquet, Dawid Maciorowski, Cheikh Diop, Emma Couto, Jillian Staiti, Mariangela Cavarelli, Laetitia Bossevot, Quentin Sconosciuti, Page Bouchard, Roger Le Grand, Luk H Vandenberghe, Nerea Zabaleta
Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates. Vaccines 12 (8) (2024)
Laura Torella, Julia Klermund, Martin Bilbao-Arribas, Ibon Tamayo, Geoffroy Andrieux, Kay O Chmielewski, Africa Vales, Cristina Olagüe, Daniel Moreno-Luqui, Ivan Raimondi, Amaya Abad, Julen Torrens-Baile, Eduardo Salido, Maite Huarte, Mikel Hernaez, Melanie Börries, Toni Cathomen, Nerea Zabaleta, Gloria Gonzalez Aseguinolaza
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO molecular medicine (2024)
Laura Torella, Julia Klermund, Martin Bilbao-Arribas, Ibon Tamayo, Geoffroy Andrieux, Kay O Chmielewski, Africa Vales, Cristina Olagüe, Daniel Moreno-Luqui, Ivan Raimondi, Amaya Abad, Julen Torrens-Baile, Eduardo Salido, Maite Huarte, Mikel Hernaez, Melanie Börries, Toni Cathomen, Nerea Zabaleta, Gloria Gonzalez Aseguinolaza
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO molecular medicine 16 (1) (2024)
Laura Torella, Julia Klermund, Martin Bilbao-Arribas, Ibon Tamayo, Geoffroy Andrieux, Kay O Chmielewski, Africa Vales, Cristina Olagüe, Daniel Moreno-Luqui, Ivan Raimondi, Amaya Abad, Julen Torrens-Baile, Eduardo Salido, Maite Huarte, Mikel Hernaez, Melanie Börries, Toni Cathomen, Nerea Zabaleta, Gloria Gonzalez Aseguinolaza
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO molecular medicine 16 (1) (2024)
Laura Torella, Julia Klermund, Martin Bilbao-Arribas, Ibon Tamayo, Geoffroy Andrieux, Kay O Chmielewski, Africa Vales, Cristina Olagüe, Daniel Moreno-Luqui, Ivan Raimondi, Amaya Abad, Julen Torrens-Baile, Eduardo Salido, Maite Huarte, Mikel Hernaez, Melanie Börries, Toni Cathomen, Nerea Zabaleta, Gloria Gonzalez Aseguinolaza
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO molecular medicine (2024)
Laura Torella, Julia Klermund, Martin Bilbao-Arribas, Ibon Tamayo, Geoffroy Andrieux, Kay O Chmielewski, Africa Vales, Cristina Olagüe, Daniel Moreno-Luqui, Ivan Raimondi, Amaya Abad, Julen Torrens-Baile, Eduardo Salido, Maite Huarte, Mikel Hernaez, Melanie Börries, Toni Cathomen, Nerea Zabaleta, Gloria Gonzalez Aseguinolaza
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO molecular medicine 16 (1) (2024)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Nerea Zabaleta, Irene Gil-Farina
Tracing the fate of AAV vectors in the body. Nature biotechnology (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Nerea Zabaleta, Carmen Unzu, Nicholas D Weber, Gloria Gonzalez Aseguinolaza
Gene therapy for liver diseases - progress and challenges. Nature reviews. Gastroenterology & hepatology (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Daniel Reichart, Gregory A Newby, Hiroko Wakimoto, Mingyue Lun, Joshua M Gorham, Justin J Curran, Aditya Raguram, Daniel M DeLaughter, David A Conner, Júlia D C Marsiglia, Sajeev Kohli, Lukas Chmatal, David C Page, Nerea Zabaleta, Luk Vandenberghe, David R Liu, Jonathan G Seidman, Christine E Seidman
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature medicine 29 (2) (2023)
Dawid Maciorowski, Cheikh Diop, Urja Bhatt, Reynette Estelien, Dan Li, Ruchi Chauhan, Luk H Vandenberghe, Nerea Zabaleta
Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging. Viruses 14 (4) (2022)